Splice variants of androgen receptor and prostate cancer

被引：5

作者：

Caffo, Orazio ^{[1
]}

Maines, Francesca ^{[1
]}

Veccia, Antonello ^{[1
]}

Kinspergher, Stefania ^{[1
]}

Galligioni, Enzo ^{[1
]}

机构：

[1] Santa Chiara Hosp, Dept Med Oncol, I-38100 Largo Medaglie Doro, Trento, Italy

来源：

ONCOLOGY REVIEWS | 2016年 / 10卷 / 01期

关键词：

Prostate cancer; splice variants; enzalutamide; abiraterone; cabazitaxel;

D O I：

10.4081/oncol.2016.297

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Over the last ten years, two new-generation hormonal drugs and two chemotherapeutic agents have been approved for the treatment of metastatic castration-resistant prostate cancer. Unfortunately, some patients have primary resistance to them and the others eventually develop secondary resistance. It has recently been suggested that the presence of androgen receptor splice variants plays a leading role in the primary and secondary resistance to the new hormonal drugs. whereas their presence seem to have only a partial effect on the activity of the chemotherapeutic agents. The aim of this paper is to review the published data concerning the role of androgen receptor splice variants in prostate cancer biology, and their potential use as biomarkers when making therapeutic decisions.

引用

页码：14 / 18

页数：5

共 57 条

[21] Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer [J].

Hu, Rong ;

Dunn, Thomas A. ;

Wei, Shuanzeng ;

Isharwal, Sumit ;

Veltri, Robert W. ;

Humphreys, Elizabeth ;

Han, Misop ;

Partin, Alan W. ;

Vessella, Robert L. ;

Isaacs, William B. ;

Bova, G. Steven ;

Luo, Jun .

CANCER RESEARCH, 2009, 69 (01) :16-22

[22]

Huggins C, 1941, CANCER RES, V1, P293

[23] The 16,17-double bond is needed for irreversible inhibition of human cytochrome P45017α by abiraterone (17-(3-pyridyl)androsta-5,16-dien-3β-ol) and related steroidal inhibitors [J].

Jarman, M ;

Barrie, SE ;

Llera, JM .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (27) :5375-5381

[24] DOMAINS OF THE HUMAN ANDROGEN RECEPTOR INVOLVED IN STEROID BINDING, TRANSCRIPTIONAL ACTIVATION, AND SUBCELLULAR-LOCALIZATION [J].

JENSTER, G ;

VANDERKORPUT, HAGM ;

VANVROONHOVEN, C ;

VANDERKWAST, TH ;

TRAPMAN, J ;

BRINKMANN, AO .

MOLECULAR ENDOCRINOLOGY, 1991, 5 (10) :1396-1404

[25] Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants [J].

Jernberg, Emma ;

Thysell, Elin ;

Ylitalo, Erik Bovinder ;

Rudolfsson, Stina ;

Crnalic, Sead ;

Widmark, Anders ;

Bergh, Anders ;

Wikstrom, Pernilla .

PLOS ONE, 2013, 8 (11)

[26] Prognostic and predictive biomarkers in prostate cancer [J].

Kontos, Christos K. ;

Adamopoulos, Panagiotis G. ;

Scorilas, Andreas .

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (12) :1567-1576

[27] Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines [J].

Li, Yingming ;

Chan, Siu Chiu ;

Brand, Lucas J. ;

Hwang, Tae Hyun ;

Silverstein, Kevin A. T. ;

Dehm, Scott M. .

CANCER RESEARCH, 2013, 73 (02) :483-489

[28] Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression [J].

Li, Yingming ;

Alsagabi, Majid ;

Fan, Danhua ;

Bova, G. Steven ;

Tewfik, Ahmed H. ;

Dehm, Scott M. .

CANCER RESEARCH, 2011, 71 (06) :2108-2117

[29] Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer [J].

Li, Zhenfei ;

Bishop, Andrew C. ;

Alyamani, Mohammad ;

Garcia, Jorge A. ;

Dreicer, Robert ;

Bunch, Dustin ;

Liu, Jiayan ;

Upadhyay, Sunil K. ;

Auchus, Richard J. ;

Sharifi, Nima .

NATURE, 2015, 523 (7560) :347-+

[30] Mechanisms of the androgen receptor splicing in prostate cancer cells [J].

Liu, L. L. ;

Xie, N. ;

Sun, S. ;

Plymate, S. ;

Mostaghel, E. ;

Dong, X. .

ONCOGENE, 2014, 33 (24) :3140-3150

← 1 2 3 4 5 6 →